The CLEVIPREX brand, founded in 2007 (United States), from 2951 sister brands and 17477 competing brands. The CLEVIPREX brand is owned by NOVARTIS N, a company listed in Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. CLEVIPREX is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(CLEVIPREX)
over 5 years*
CHF 93.85